Oct. 16 at 6:32 PM
The biotech equipment sector is entering a new growth cycle — projected to hit
$144B by 2030, fueled by advances in cell & gene therapy, automation, and AI-driven manufacturing. Emergers like Cryoport (
$CYRX), Seer (
$SEER), and BioLife Solutions (
$BLFS) are powering this shift with innovations in cold-chain logistics, proteomics, and bioprocessing systems.
https://prismmarketview.com/prism-bioview-dive-recent-report-projects-global-biotech-equipment-market-to-accelerate-toward-144bn-by-2030-heres-who-to-watch/